1.Hereditary Leiomyomatosis and Renal Cell Cancer: A Case Report of Pilar Leiomyomatosis with History of Kidney Cancer and Review of the Literature
Jee-Woo KIM ; Jung-Won SHIN ; Anna CHO ; Chang-Hun HUH
Annals of Dermatology 2023;35(Suppl1):S14-S18
Pilar leiomyoma or piloleiomyoma is a benign neoplasm of the smooth muscle arising from the arrector pili muscle. It manifests as brown to red firm papulonodules with sites of predilection being the face, trunk, and extensor surfaces of the extremities. Histologically, the lesions exhibit ill-defined dermal tumors with interlacing fascicles of spindle cells. Some genodermatoses are characterized by the development of visceral tumors and cutaneous leiomyomatosis such as Reed’s syndrome, and hereditary leiomyomatosis and renal cell cancer (HLRCC). A 55-year-old male presented with reddish-brown papules and nodules on the face and upper back, accompanied by sharp episodic pain on the face. He had undergone nephrectomy for renal cancer 9 years ago, and his younger brother had similar cutaneous manifestation. Histopathologic findings were consistent with pilar leiomyoma, showing bundles of smooth muscle tumors in the dermis. Based on the clinical information including clinical features, past medical history, and family history, HLRCC was highly suspected.To confirm the diagnosis, whole exome sequencing was performed using peripheral blood, which revealed a novel point mutation (c.739G>A, p.Glu247Lys) in the fumarate hydratase (FH) gene. We describe a confirmed case of HLRCC, which is a genetic disorder with a potential to cause visceral cancers, which dermatologists might overlook as a benign condition.
2.Two‑dimensional transthoracic measure of mitral annulus in mitral valve prolapse and moderate to severe regurgitation: a method comparison analysis with three‑dimensional transesophageal echocardiography
Maxime BERTHELOT‑RICHER ; Halyna Viktorivna VAKULENKO ; Anna CALLEJA ; Anna WOO ; Paaladinesh THAVENDIRANATHAN ; Frédéric POULIN
Journal of Cardiovascular Imaging 2024;32(1):2-
Background:
Mitral annulus (MA) area is derived during transthoracic echocardiography (TTE) assuming of a circu‑ lar shape using the MA diameter from the apical 4 chamber (A4c) view. Since the MA is not a circular structure, we hypothesized that an elliptical model using parasternal long-axis (PLAX) and apical 2 chamber (A2c) view measured MA diameters would have better agreement with 3-dimensional transesophageal echocardiography (3D TEE) meas‑ ured MA in degenerative mitral valve disease (DMVD).
Methods:
Seventy-six patients with moderate-to-severe DMVD had 2D TTE and 3D TEE performed. MA area was measured retrospectively using semi-automatic modeling of 3D data (3D TEEsa ) and considered as the reference method. MA diameters were measured using different 2D TTE views. MA area was calculated using assumptions of a circular or an elliptical shape. 2D TTE derived and 3D TEEsa . MA areas were compared using linear regression and Bland-Altman analysis.
Results:
The median MA area measured at 3D TEEsa was 1,386 (1,293–1,673) mm2 . With 2D TTE, the circular model using A4c view diameter resulted in a small systematic underestimation of MA area (6%), while the elliptical model using PLAX and A2c diameters resulted in 25% systematic underestimation. The standard deviations of the distribu‑tions of inter-method differences were wide for all 2D TTE methods (265–289 mm2 ) when compared to 3D TEEsa , indicating imprecision.
Conclusions
When compared with 3D TEEsa modeling of the MA as the reference, the assumption of a circular shapeusing A4c TTE view diameter was the method with the least systematic error to assess MA area in DMVD and moder‑ ate to severe regurgitation.
3.A Case of Obstructive Jaundice Caused by Paradoxical Reaction during Antituberculous Chemotherapy for Abdominal Tuberculosis.
Yun Jung LEE ; Sung Hee JUNG ; Woo Jin HYUN ; Sae Hee KIM ; Hyang Ie LEE ; Hyeon Woong YANG ; Anna KIM ; Sang Woo CHA
Gut and Liver 2009;3(4):338-342
Abdominal tuberculosis is not a rare disease, but obstructive jaundice caused by tuberculosis (tuberculous lymphadenitis, tuberculous enlargement of the head of pancreas, and/or tuberculous stricture of the biliary tree) is rare. We recently experienced a case of obstructive jaundice as a result of paradoxical reaction of periportal tuberculous lymphadenopathy that was treated successfully with corticosteroid and biliary drainage. No similar cases have been reported previously.
Constriction, Pathologic
;
Drainage
;
Head
;
Jaundice, Obstructive
;
Lymphatic Diseases
;
Pancreas
;
Rare Diseases
;
Tuberculosis
;
Tuberculosis, Lymph Node
4.A Case of Gastrointestinal Amyloidosis in Asymptomatic Multiple Myeloma.
Sae Hee KIM ; Yun Jung LEE ; Sung Hee JUNG ; Woo Jin HYEON ; Hyang Ie LEE ; Hyeon Woong YANG ; Anna KIM ; Sang Woo CHA ; Dong Wook KANG
Intestinal Research 2009;7(2):123-128
Amyloidosis is a disorder characterized by extracellular deposition of amyloid materials in multiple organs and tissues. Amyloidosis commonly shows a systemic involvement. Gastrointestinal involvement is common in amyloidosis and is usually asymptomatic. The gastrointestinal manifestations include gastroparesis, diarrhea, steatorrhea, constipation, intestinal pseudo-obstruction, and bleeding. The diagnosis of amyloidosis is difficult because there are absence of systemic symptoms and nonspecific endoscopic findings. Asymptomatic multiple myeloma is an asymptomatic plasma-cell proliferative disorder associated with a high risk of progression to symptomatic multiple myeloma or amyloidosis. Recently, we experienced a 60-year-old man who presented with hematochezia and weight loss as manifestations of gastrointestinal amyloidosis involving the stomach and the colon induced in asymptomatic multiple myeloma confirmed by endoscopic biopsies and bone marrow biopsy. We report a case with a review of the literature.
Amyloid
;
Amyloidosis
;
Biopsy
;
Bone Marrow
;
Colon
;
Constipation
;
Diarrhea
;
Gastrointestinal Hemorrhage
;
Gastroparesis
;
Hemorrhage
;
Humans
;
Intestinal Pseudo-Obstruction
;
Middle Aged
;
Multiple Myeloma
;
Steatorrhea
;
Stomach
;
Weight Loss
5.A Case of Gastrointestinal Amyloidosis in Asymptomatic Multiple Myeloma.
Sae Hee KIM ; Yun Jung LEE ; Sung Hee JUNG ; Woo Jin HYEON ; Hyang Ie LEE ; Hyeon Woong YANG ; Anna KIM ; Sang Woo CHA ; Dong Wook KANG
Intestinal Research 2009;7(2):123-128
Amyloidosis is a disorder characterized by extracellular deposition of amyloid materials in multiple organs and tissues. Amyloidosis commonly shows a systemic involvement. Gastrointestinal involvement is common in amyloidosis and is usually asymptomatic. The gastrointestinal manifestations include gastroparesis, diarrhea, steatorrhea, constipation, intestinal pseudo-obstruction, and bleeding. The diagnosis of amyloidosis is difficult because there are absence of systemic symptoms and nonspecific endoscopic findings. Asymptomatic multiple myeloma is an asymptomatic plasma-cell proliferative disorder associated with a high risk of progression to symptomatic multiple myeloma or amyloidosis. Recently, we experienced a 60-year-old man who presented with hematochezia and weight loss as manifestations of gastrointestinal amyloidosis involving the stomach and the colon induced in asymptomatic multiple myeloma confirmed by endoscopic biopsies and bone marrow biopsy. We report a case with a review of the literature.
Amyloid
;
Amyloidosis
;
Biopsy
;
Bone Marrow
;
Colon
;
Constipation
;
Diarrhea
;
Gastrointestinal Hemorrhage
;
Gastroparesis
;
Hemorrhage
;
Humans
;
Intestinal Pseudo-Obstruction
;
Middle Aged
;
Multiple Myeloma
;
Steatorrhea
;
Stomach
;
Weight Loss
6.The role of flexible sigmoidoscopy in the diagnosis of Clostridium difficile-associated diarrhea.
Sae Hee KIM ; Sung Hee JUNG ; Yun Jung LEE ; Woo Jin HYEON ; Young Wook YOO ; Hyang Ie LEE ; Hyeon Woong YANG ; Anna KIM ; Sang Woo CHA
Korean Journal of Medicine 2010;78(3):318-324
BACKGROUND/AIMS: Clostridium difficile is an important cause of diarrhea in hospitalized patients. C. difficile-associated diarrhea (CDAD) is usually diagnosed following a stool test for C. difficile cytotoxin or stool culture for the presence of toxigenic C. difficile. However, the reported sensitivities of these tests are variable. Sigmoidoscopy may be an effective diagnostic method in patients with a false-negative stool test for cytotoxin. This study examined the role of flexible sigmoidoscopy in the diagnosis of CDAD. METHODS: Among the patients who had diarrhea and were examined with sigmoidoscopy in Eulji University Hospital between January 2005 and July 2008, 102 patients suspected of having antibiotic-associated diarrhea (AAD) based on their clinical symptoms were enrolled. Of the 102 patients, 74 were diagnosed with CDAD based on C. difficile cytotoxin or sigmoidoscopic findings of pseudomembranous colitis. The medical records of these 74 patients were reviewed retrospectively. RESULTS: Of the 74 patients, sigmoidoscopic findings revealed a pseudomembrane in 63 patients (85.1%) and colitis in nine (12.2%), while two patients (2.7%) appeared normal. Of the 63 patients with pseudomembranous colitis at sigmoidoscopy, the stool C. difficile cytotoxin assay was negative in 27 (42.9%). CONCLUSIONS: Flexible sigmoidoscopy was highly sensitive in pseudomembranous colitis and is useful in diagnosing patients with a delayed or negative stool test for C. difficile cytotoxin. Therefore, we recommend flexible sigmoidoscopy in patients suspected of having C. difficile-associated diarrhea for the diagnosis of CDAD.
Clostridium
;
Clostridium difficile
;
Colitis
;
Diarrhea
;
Enterocolitis, Pseudomembranous
;
Humans
;
Medical Records
;
Sigmoidoscopy
7.A case of variceal bleeding from the jejunum in liver cirrhosis.
Chan Woong PARK ; Sae Hee KIM ; Hyeon Woong YANG ; Yun Jung LEE ; Sung Hee JUNG ; Ho Sup SONG ; Sang Ok LEE ; Anna KIM ; Sang Woo CHA
Clinical and Molecular Hepatology 2013;19(1):78-81
While esophagogastric varices are common manifestations of portal hypertension, variceal bleeding from the jejunum is a rare complication of liver cirrhosis. In addition, ectopic variceal bleeding occurs in the duodenum and at sites of previous bowel surgery in most cases, including of stomas. We report a case of obscure overt gastrointestinal bleeding from jejunal varices in a 55-year-old woman who had not previously undergone abdominal surgery, who had liver cirrhosis induced by the hepatitis C virus. Emergency endoscopy revealed the presence of esophageal varices without stigmata of recent bleeding, and no bleeding focus was found at colonoscopy. She continued to produce recurrent melena with hematochezia and received up to 21 units of packed red blood cells. CT angiography revealed the presence of jejunal varices, but no active bleeding was found. Capsule endoscopy revealed fresh blood in the jejunum. The patient submitted to embolization of the jejunal varices via the portal vein, after which she had a stable hemoglobin level and no recurrence of the melena. This is a case of variceal bleeding from the jejunum in a liver cirrhosis patient without a prior history of abdominal surgery.
Angiography
;
Capsule Endoscopy
;
Embolization, Therapeutic
;
Esophageal and Gastric Varices/complications/diagnosis
;
Female
;
*Gastrointestinal Hemorrhage
;
Humans
;
Hypertension, Portal
;
Jejunal Diseases/*diagnosis/therapy
;
Liver Cirrhosis/*diagnosis
;
Melena/complications
;
Middle Aged
;
Tomography, X-Ray Computed
8.A Field Efficacy Trial of Inactivated Hantaan Virus Vaccine (Hantavax(TM)) Against Hemorrhagic Fever with Renal Syndrome (HFRS) in the Endemic Areas of Yugoslavia from 1996 to 1998.
Young Kyu CHU ; Anna GLIGIC ; Snezana TOMANOVIC ; Boyana BOZOVJC ; Mirceta OBRADOVIC ; Young Dae WOO ; Chang Nam AN ; Hun KIM ; Yang Seok JIANG ; Seung Chul PARK ; Min Ja KIM ; Eun Il LEE ; Ho Wang LEE
Journal of the Korean Society of Virology 1999;29(2):55-64
In Yugoslavia, homorrhagic fever with renal syndrome (HFRS) is one of the important national health problem, but no vaccine has been used to prevent HFRS. Since first HFRS case in 1952, sporadic cases of HFRS occurred every year and over 4,000 registered cases with 1~16% mortality so far. We performed a prospective, randomized double-blind placebo-controlled trial to evaluate the effectiveness of Hantavax(TM) against HFRS in 3,900 healthy adults living in the endemic areas of Yugoslavia. 1,900 people were given 0.5 ml of Hantavax subcutaneously twice at one month interval and a booster shot at one year after. For controls other 2,000 healthy people were given 0.5 ml of physiolosical saline as a placebo. We investigated HFRS cases in both the vaccinated and nonvaccinated groups by monitoring the program for patient registration in the areas from 1996 to 1998, and the effect of vaccine was analyzed epidemiologically No confirmed case of HFRS was observed among 1,900 Hantavax vaccinees, while 20 confirmed cases were observed among 2,000 nonvaccinated control group. There were no remarkable side effects among the vaccinees either locally or in general after inoculation of the vaccine. The Hantavax vaccine showed statistically significant protective efficacy against HFRS among Yugoslavian people.
Adult
;
Fever
;
Hantaan virus*
;
Hantavirus
;
Hemorrhagic Fever with Renal Syndrome*
;
Humans
;
Mortality
;
Prospective Studies
;
Yugoslavia*
9.A Field Efficacy Trial of Inactivated Hantaan Virus Vaccine (Hantavax(TM)) Against Hemorrhagic Fever with Renal Syndrome (HFRS) in the Endemic Areas of Yugoslavia from 1996 to 1998.
Young Kyu CHU ; Anna GLIGIC ; Snezana TOMANOVIC ; Boyana BOZOVJC ; Mirceta OBRADOVIC ; Young Dae WOO ; Chang Nam AN ; Hun KIM ; Yang Seok JIANG ; Seung Chul PARK ; Min Ja KIM ; Eun Il LEE ; Ho Wang LEE
Journal of the Korean Society of Virology 1999;29(2):55-64
In Yugoslavia, homorrhagic fever with renal syndrome (HFRS) is one of the important national health problem, but no vaccine has been used to prevent HFRS. Since first HFRS case in 1952, sporadic cases of HFRS occurred every year and over 4,000 registered cases with 1~16% mortality so far. We performed a prospective, randomized double-blind placebo-controlled trial to evaluate the effectiveness of Hantavax(TM) against HFRS in 3,900 healthy adults living in the endemic areas of Yugoslavia. 1,900 people were given 0.5 ml of Hantavax subcutaneously twice at one month interval and a booster shot at one year after. For controls other 2,000 healthy people were given 0.5 ml of physiolosical saline as a placebo. We investigated HFRS cases in both the vaccinated and nonvaccinated groups by monitoring the program for patient registration in the areas from 1996 to 1998, and the effect of vaccine was analyzed epidemiologically No confirmed case of HFRS was observed among 1,900 Hantavax vaccinees, while 20 confirmed cases were observed among 2,000 nonvaccinated control group. There were no remarkable side effects among the vaccinees either locally or in general after inoculation of the vaccine. The Hantavax vaccine showed statistically significant protective efficacy against HFRS among Yugoslavian people.
Adult
;
Fever
;
Hantaan virus*
;
Hantavirus
;
Hemorrhagic Fever with Renal Syndrome*
;
Humans
;
Mortality
;
Prospective Studies
;
Yugoslavia*
10.A Case of Metastatic Renal Cell Carcinoma Bleeding of the Pancreas Manifesting As Cholangitis.
Su A YUN ; Hyun Cheol KOO ; Ji Woong JANG ; Anna KIM ; Yong Sik KIM ; Sung Hee JUNG ; Sae Hee KIM ; Woo Kyung SUNG
Korean Journal of Pancreas and Biliary Tract 2014;19(2):101-104
Renal cell carcinoma (RCC) is the second most common urological malignancy and it has diverse range of clinical manifestation. One third of the patients show the metastasis at the time of the diagnosis. The common sites of metastasis are the lung, bone, lymph nodes and metastasis to the pancreas is rare. In case of pancreatic metastasis, more than half of the patients are asymptomatic. Patients with symptoms visit hospital complaining of abdominal pain, weight loss, steatorrhea and rarely biliary obstruction. Although about 40% of all patients visit hospital with hemorrhage, cholangitis caused by spontaneous pancreatic hemorrhage is rare. We report an interesting case of 61-year-old woman with cholangitis caused by bleeding due to pancreatic metastasis from renal cell carcinoma.
Abdominal Pain
;
Carcinoma, Renal Cell*
;
Cholangitis*
;
Diagnosis
;
Female
;
Hemorrhage*
;
Humans
;
Lung
;
Lymph Nodes
;
Middle Aged
;
Neoplasm Metastasis
;
Pancreas*
;
Steatorrhea
;
Weight Loss